Recent News

and/or

12 News Items found

In the Clinic

Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.

A tube of blood superimposed on a lung and a DNA helix

Feature

What Is Epigenetics, and Why Is Everyone Talking about It?

Epigenetics is frequently in the news, but there's lots of confusion about just what it entails.

A calico cat

In the Lab

Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

Blue cells containing small red and green dots on a black background

In the Clinic

Genetic ‘Scars’ Provide Clues for Tailoring Cancer Treatment

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.

Image of DNA helix with sequence in the background

Feature

With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care

Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.

In the Lab

Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

MSK investigators Joan Massagué and Anna Obenauf

Decoder

What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Exceptional responders of new drugs in clinical trials.

Profile

At Work: Physician-Scientist David Solit

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: David Solit

Announcement

Bold Initiative to Transform Cancer Care Established with a $100 Million Gift

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit

In the Lab

Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell